What are the key points to cover in a 30-minute seminar on shock management in an emergency medicine department?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Shock Management Seminar for Emergency Medicine Department

Classification of Shock: Four Primary Categories

Shock is defined by sustained systolic blood pressure <90 mmHg for ≥30 minutes with evidence of end-organ hypoperfusion (elevated lactate, altered mental status, cold extremities, or decreased urine output), and must be classified into one of four phenotypes to guide treatment: hypovolemic, distributive (septic), cardiogenic, or obstructive. 1, 2

  • Hypovolemic shock: Intravascular volume loss requiring fluid replacement 2
  • Distributive shock: Pathological redistribution of blood volume (sepsis most common) requiring vasoconstrictors plus fluids 2
  • Cardiogenic shock: Primary cardiac dysfunction requiring inotropes/mechanical support 2
  • Obstructive shock: Elevated resistance from mechanical blockage requiring immediate intervention 2

First Hour Resuscitation: The Golden Hour

Within 60 minutes, achieve capillary refill ≤2 seconds, normalized heart rate, and systolic blood pressure ≥90 mmHg in adults. 1

Immediate Actions for All Shock Types

  • Administer 20 mL/kg boluses of isotonic crystalloid (normal saline or lactated Ringer's) up to and exceeding 60 mL/kg until perfusion improves or fluid overload develops. 1
  • Obtain ECG and echocardiography immediately to identify shock phenotype and guide management 3, 1
  • Establish invasive arterial line for continuous blood pressure monitoring 3, 1
  • Monitor capillary refill, mental status, urine output (target >0.5 mL/kg/hr), and lactate levels 4, 1

Septic/Distributive Shock Management

Norepinephrine is the first-line vasopressor after appropriate fluid resuscitation, targeting mean arterial pressure ≥65 mmHg. 1

Initial Resuscitation Protocol

  • Administer at least 30 mL/kg IV crystalloid within the first 3 hours of sepsis-induced hypoperfusion. 4
  • Begin empiric antibiotics within 1 hour of identifying severe sepsis; obtain blood cultures before antibiotics but do not delay administration 4
  • Reassess hemodynamic status frequently using clinical examination, heart rate, blood pressure, oxygen saturation, respiratory rate, temperature, and urine output 4

Vasopressor Selection

  • Start norepinephrine as first-line agent over dopamine due to lower arrhythmia risk. 4, 1
  • Epinephrine may be added if norepinephrine alone is insufficient 5, 6
  • Target ScvO2 ≥70% and cardiac index between 3.3-6.0 L/min/m² in pediatric patients 4

Cardiogenic Shock Management

Cardiogenic shock is defined by hypotension (SBP <90 mmHg) despite adequate filling status plus signs of hypoperfusion: oliguria, cold peripheries, altered mental status, lactate >2 mmol/L, metabolic acidosis, or SvO2 <65%. 4

Immediate Assessment and Monitoring

  • Perform ECG and echocardiography immediately in all suspected cases 4, 3
  • Establish invasive arterial line monitoring 4, 3
  • Consider pulmonary artery catheter for refractory shock to measure cardiac index, PCWP, and cardiac power output 4, 3, 1

Pharmacological Management

  • Attempt fluid challenge (200 mL saline or Ringer's lactate over 15-30 minutes) first if no overt fluid overload is present. 4
  • Dobutamine (2-20 mcg/kg/min) is first-line for myocardial dysfunction with adequate blood pressure. 3, 1
  • Use norepinephrine over dopamine if vasopressor support is needed to maintain systolic blood pressure. 4
  • Levosimendan may be considered, especially in patients on beta-blockers 4, 3

Mechanical Circulatory Support Criteria

  • Consider mechanical circulatory support when cardiac index <2.2 L/min/m², cardiac power output <0.6 W, and elevated lactate persist despite initial therapy. 3
  • Transfer immediately to tertiary center with 24/7 cardiac catheterization and mechanical circulatory support capabilities 4
  • Intraaortic balloon pump is not routinely recommended 4

Hypovolemic/Hemorrhagic Shock Management

Initiate crystalloid resuscitation immediately and apply isotonic crystalloids or albumin in 20 mL/kg boluses over 5-10 minutes, titrated to reverse hypotension and restore perfusion. 4

Trauma-Specific Considerations

  • Avoid hypotonic solutions like Ringer's lactate in patients with severe head trauma 4
  • Implement damage control surgery for deep hemorrhagic shock with ongoing bleeding, coagulopathy, hypothermia, or acidosis 4
  • Perform immediate pelvic ring closure and stabilization for pelvic ring disruption with hemorrhagic shock 4

Obstructive Shock: Reversible Causes

Immediately evaluate for and reverse pneumothorax, pericardial tamponade, pulmonary embolism, or tension physiology in patients with refractory shock. 4, 1

  • Consider endocrine emergencies (hypoadrenalism, hypothyroidism) in refractory cases 4
  • Evaluate for intra-abdominal hypertension in select patients 4, 1

Advanced Hemodynamic Monitoring

Use pulmonary artery catheter, transpulmonary thermodilution (PiCCO), or echocardiography to guide therapy in refractory shock. 1

Key Parameters to Monitor

  • Pulmonary capillary wedge pressure (PCWP) 1
  • Pulmonary artery pulsatility index (PAPI) 1
  • Cardiac power output 1
  • Cardiac index (CI) 1

Critical caveat: PCWP may not accurately reflect left ventricular end-diastolic pressure in certain conditions, and pressure estimates are generally insensitive indicators of volume status. 1


Pediatric-Specific Considerations

Follow ACCM-PALS guidelines for pediatric septic shock management. 4

Resuscitation Endpoints in Children

  • Capillary refill <2 seconds 4
  • Normal blood pressure for age 4
  • Normal pulses with no differential between peripheral and central 4
  • Warm extremities 4
  • Urine output >1 mL/kg/hr 4
  • Normal mental status 4

Inotrope Selection in Pediatrics

  • Individualized titration with epinephrine, levosimendan, dopamine, or dobutamine based on hemodynamic phenotype. 3
  • Use dopamine cautiously at doses >7 mcg/kg/min as it may increase pulmonary vascular resistance. 3
  • Begin peripheral inotropic support until central venous access is obtained in fluid-refractory patients 4

ECMO Considerations

  • Consider ECMO early for refractory cardiogenic shock in pediatric myocarditis unresponsive to pharmacological therapy. 3
  • Pre-cardiac arrest ECMO use may be beneficial in acute fulminant myocarditis 3

Common Pitfalls to Avoid

  • Do not rely solely on blood pressure for assessment; always evaluate tissue perfusion markers (lactate, mental status, urine output, capillary refill). 3, 1
  • Do not delay echocardiographic evaluation in suspected cardiogenic shock. 3
  • Do not continue aggressive fluid resuscitation if hepatomegaly or rales develop; switch to inotropic support. 4
  • Do not use dopamine as first-line vasopressor in septic shock due to increased arrhythmia risk compared to norepinephrine. 4, 1

Refractory Shock Management

Rule out and correct reversible causes: pericardial effusion, pneumothorax, intra-abdominal hypertension, and endocrine emergencies. 1

  • Initiate continuous renal replacement therapy if fluid overload exceeds 10% despite diuretics 1
  • Reassess shock phenotype and consider mechanical circulatory support for cardiogenic shock 1
  • Verify adequate source control in septic shock 4

References

Guideline

Management of Shock in the ICU

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The Nomenclature, Definition and Distinction of Types of Shock.

Deutsches Arzteblatt international, 2018

Guideline

Initial Management of Cardiogenic Shock Due to Myocarditis in Pediatrics

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.